Research Collaborations
To stay at the forefront, AcouSort is continuously developing the acoustofluidic technology further together with universities and commercial partners.
AcouSome
Using AcouSort’s technologies and the thin-film actuation materials developed in BioWings to separate out exosomes from blood for research and future diagnostics.
The AcouSome team of companies and universities coordinated by AcouSort is funded by the European Innovation Council’s EIC Transition programme with 2.5 MEUR out of which 1.1 MEUR to AcouSort for this three-year project.
Blue4Therapy
Development of a platform for specific stem cell isolation from autologous adipose tissue for effective regenerative therapy, together with universities and commercial partners.
The project has received funding from the Eurostarts-2 joint programme with co-funding from the European Union Horizon 2020 research and innovation programme. The Swedish part is funded by Sweden’s Innovation Agency Vinnova.
Read More
IndiCell
Development of a world leading innovation milieu for individualized induced pluripotent stem cell derived therapies, to lower the risks and overcome hurdles for the translation from basic science to innovations and further to clinical applications. The project includes partners within academia, health care and the commercial sector.
The project has received funding by Sweden’s Innovation Agency (Vinnova) through the Innovation milieus in precision Health 2021 program.
AcouPlast
Development of polymer acoustophoresis chips together with universites and commercial partners to make acoustofluidics even more versatile, cost efficient and easy to integrate into diagnostic and analytical systems.
The project has received funding from the Eurostarts-2 joint programme with co-funding from the European Union Horizon 2020 research and innovation programme. The Swedish part is funded by Sweden’s Innovation Agency Vinnova.
Centre for Advanced Medical Products (CAMP)
Development of cell processing together with universities and commercial partners.
The project is funded by Sweden’s Innovation Agency Vinnova.
Previous projects
BioWings (2018-2022)
Development of actuation materials together with universities and commercial partners to make acoustofluidic chips more efficient and easier to manufacture. The project received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 801267.
Read MoreLeucocyte isolation based on acoustophoresis (LIBA, 2014-2015)
Development of acoustofluidic separation of mononuclear cells (MNCs) from blood in collaboration with Lund University and Skåne University Hospital. The project was funded by Sweden’s Innovation Agency Vinnova.
Read MoreA unique tool for the isolation of cells including cancer diagnostics and microbiology (2014-2015)
Development of an acoustofluidic instrument for cell and particle handling. The project was funded by the Sten K Johnson Foundation.
Read MoreAcouPlasma (2018-2019)
The AcouPlasma SME instrument project developed the business plan and strategy for AcouSort’s market positioning of a cost-effective Lab-on-a-chip solution for blood plasma separation, intended for integration into plasma-based diagnostic devices. The project was funded by the European Union’s Horizon 2020 research and innovation programme.
Read More